期刊文献+

慢性心力衰竭并房颤患者出院1年全因死亡因素预测

Predictors of 1-year All-cause Death in Patients with Chronic Heart Failure and Atrial Fibrillation
下载PDF
导出
摘要 目的:探讨老年慢性心力衰竭合并房颤患者出院后随访1年全因死亡的因素预测。方法:选择2019年1月-2020年3月在石河子大学医学院第一附属医院住院治疗的老年慢性心力衰竭合并房颤患者233例,收集一般资料,对患者随访1年,记录有无全因死亡事件;把发生终点事件与未发生终点事件患者的一般资料进行对比,筛选单因素分析有统计学意义的变量进行多因素Logistic回归分析。结果:未发生终点事件与发生终点事件患者的资料进行对比发现:两组间性别、年龄、服药总数、总胆固醇、甘油三酯、低密度脂蛋白、白细胞计数、血小板计数、血红蛋白差异无统计学意义(P>0.05);共病总数、Barthel指数评分、心功能分级、血肌酐、白蛋白、D二聚体、LVEF值、病程差异有统计学意义(P<0.05);筛选单因素分析有统计学意义的变量进行多因素Logistic回归分析表明,老年慢性心力衰竭合并房颤患者出院1年全因死亡与Barthel指数评分、NYHA心功能分级、慢性心力衰竭病程密切相关(P<0.05)。结论:慢性心力衰竭病程长、NYHA分级高是老年慢性心力衰竭合并房颤患者出院1年全因死亡的独立危险因素,而Barthel指数评分高是老年慢性心力衰竭合并房颤患者出院1年全因死亡的保护因素。 Objective:To investigate the risk factors of one-year all-cause death in elderly patients with chronic heart failure and atrial fibrillation.Methods:A total of 233 elderly patients with chronic heart failure and atrial fibrillation who were hospitalized in the First Affiliated Hospital of Shihezi University from January 2019 to March 2020 were selected.The general data were collected.The patients were followed up for 1 year to record whether there were all-cause deaths.The general data of patients with and without endpoint events were compared,and the variables with statistical significance in univariate analysis were selected for multivariate logistic regression analysis.Results:There was no significant difference in gender,age,total dosage total cholesterol,triglyceride,low density lipoprotein,white blood cell count,platelet count and hemoglobin between the two groups(P>0.05).The total number of comorbidities,Barthel index score,cardiac function grade,serum creatinine,albumin,D-dimer,the course of chronic heart failure and LVEF were significantly different(P<0.05).Multivariate logistic regression analysis showed that Barthel index score,NYHA cardiac function classification and the course of chronic heart failure were closely related to all-cause death in elderly patients with chronic heart failure complicated with atrial fibrillation in one year after discharge(P<0.05).Conclusion:Long course of chronic heart failure and high NYHA grade are independent risk factors for all-cause death in elderly patients with chronic heart failure complicated with atrial fibrillation,while high Barthel index score is a protective factor for all-cause death in elderly patients with chronic heart failure complicated with atrial fibrillation.
作者 梁晓娜 罗文利 魏丽静 LIANG Xiao-na;LUO Wen-li;WEI Li-jing(Shihezi Univerisity School of Medicine,Xinjiang Shihezi,832002;The second Department of veteran cadres,the First Affiliated Hospital of Shihezi Univerisity School of Medicine,Xinjiang Shihezi,832008)
出处 《农垦医学》 2021年第2期129-131,142,共4页 Journal of Nongken Medicine
关键词 慢性心力衰竭 房颤 全因死亡 预后 回归分析 Chronic heart failure Atrial fibrillation All cause death Prognosis Regression analysis
  • 相关文献

参考文献8

二级参考文献65

  • 1托伐普坦临床研究协作组,张健,朱文玲.常规治疗基础上联用托伐普坦片治疗心原性水肿的有效性和安全性的多中心随机、双盲、安慰剂对照研究[J].中华心力衰竭和心肌病杂志(中英文),2017,1(1):15-21. 被引量:26
  • 2Kim JH, Malhotra R, Chiampas G, et al. Cardiac arrest during long-distance running races. The New England journal of medicine 2012; 366(2): 130-40.
  • 3Maron BJ, Haas TS, Murphy CJ, Ahluwalia A, Rutten-Ramos S Incidence and causes of sudden death in U.S. college athletes Journal of the American College of Cardiology 2014; 63(16) 1636-43.
  • 4Maron B J, Maron MS. Hypertrophic cardiomyopathy. Lancet 2013: 381(9862): 242-55.
  • 5Zou Y, Song L, Wang Z, et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. The American journal of medicine 2004; 116(1): 14-8.
  • 6Force T, Bonow RO, Houser SR, et al. Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute. Circulation 2010; 12201): 1130-3.
  • 7Authors/Task Force m, Elliott PM, Anastasakis A, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). European heart journal 2014; 35(39): 2733-79.
  • 8Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124(24): 2761-96.
  • 9Maron B J, Spirito P, Shen WK, et al. Implantable cardioverter- defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. Jama 2007; 298(4): 405-12.
  • 10Kwon DH, Smedira NG, Rodriguez ER, et al. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. Journal of the American College of Cardiology 2009; 54(3): 242-9.

共引文献5489

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部